Surgical resection of pheochromocytoma is associated with a high risk of intraoperative hemodynamic instability owing to abrupt changes in tumoral catecholamine secretion. A study by Bruynzeel et al. has now assessed preoperative risk factors and the efficacy of presurgical treatment with two different α-adrenergic receptor antagonists.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Risk factors for prolonged hypotension in patients with pheochromocytoma undergoing laparoscopic adrenalectomy: a single-center retrospective study
Scientific Reports Open Access 19 July 2017
-
Cement-augmented dorsal instrumentation of the spine as a safe adjunct to the multimodal management of metastatic pheochromocytoma: a case report
Patient Safety in Surgery Open Access 05 January 2012
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Bruynzeel, H. et al. Risk factors for hemodynamic instability during surgery for pheochromocytoma. J. Clin. Endocrinol. Metab. 95, 678–685 (2010).
Kinney, M. A. et al. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth. Analg. 91, 1118–1123 (2000).
Plouin, P. F., Duclos, J. M., Soppelsa, F., Boublil, G. & Chatellier, G. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J. Clin. Endocrinol. Metab. 86, 1480–1486 (2001).
Pacak, K. Preoperative management of the pheochromocytoma patient. J. Clin. Endocrinol. Metab. 92, 4069–4079 (2007).
Mannelli, M. Management and treatment of pheochromocytomas and paragangliomas. Ann. NY Acad. Sci. 1073, 405–416 (2006).
Pacak, K. et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat. Clin. Pract. Endocrinol. Metab. 3, 92–102 (2007).
Prys-Roberts, C. & Farndon, J. R. Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J. Surg. 26, 1037–1042 (2002).
Eisenhofer, G. et al. Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma. Am. J. Physiol. Endocrinol. Metab. 295, E1223–E1233 (2008).
Eisenhofer, G. et al. Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management. Drug Saf. 30, 1031–1062 (2007).
Bornstein, S. R. Predisposing factors for adrenal insufficiency. N. Engl. J. Med. 360, 2328–2339 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Eisenhofer, G., Bornstein, S. Risks of hemodynamic instability in pheochromocytoma. Nat Rev Endocrinol 6, 301–302 (2010). https://doi.org/10.1038/nrendo.2010.65
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2010.65
This article is cited by
-
Risk factors for prolonged hypotension in patients with pheochromocytoma undergoing laparoscopic adrenalectomy: a single-center retrospective study
Scientific Reports (2017)
-
Cement-augmented dorsal instrumentation of the spine as a safe adjunct to the multimodal management of metastatic pheochromocytoma: a case report
Patient Safety in Surgery (2012)